Liu Jiao, Chen Liyan, Yang Jing, Wang Lan, Shang Huifang, Chen Xueping
Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
Department of Neurology, Chongqing People's Hospital, Chongqing, China.
Front Neurol. 2020 Nov 26;11:593680. doi: 10.3389/fneur.2020.593680. eCollection 2020.
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis and sporadic Creutzfeldt-Jakob disease (sCJD) share similar clinical features. Here, we present two unusual cases of anti-NMDAR encephalitis who were misdiagnosed as sCJD at first. We described two patients' clinical manifestations, as well as the string of symptomatological evolution, treatments, and follow-up results. Our patients presented with rapidly progressive dementia, memory problems, psychiatric symptoms, and movement disorders, and we considered all these symptoms as a presenting feature of sCJD at first, but the cerebrospinal fluid examination showed positive results for both the 14-3-3 protein and antibodies against NMDAR. Immunomodulatory treatment led to a resolution of these deficits, and both of them remained in remission after treatment. Anti-NMDAR encephalitis can present with rapidly progressive cognitive decline, and sometimes laboratory investigations can be misleading. The examination for the presence of NMDAR antibodies is necessary, even with the presence of 14-3-3 protein. Early immunomodulatory therapy should be considered, especially for patients with high titers of NMDAR antibodies.
抗 N-甲基-D-天冬氨酸受体(NMDAR)脑炎与散发性克雅氏病(sCJD)具有相似的临床特征。在此,我们报告两例不寻常的抗 NMDAR 脑炎病例,最初均被误诊为 sCJD。我们描述了两位患者的临床表现、一系列症状演变过程、治疗情况及随访结果。我们的患者起初表现为快速进展性痴呆、记忆问题、精神症状和运动障碍,我们最初将所有这些症状视为 sCJD 的特征表现,但脑脊液检查显示 14-3-3 蛋白和抗 NMDAR 抗体均呈阳性。免疫调节治疗使这些缺陷得到缓解,且两位患者治疗后均保持病情缓解状态。抗 NMDAR 脑炎可表现为快速进展的认知衰退,有时实验室检查结果可能会产生误导。即使存在 14-3-3 蛋白,检测 NMDAR 抗体也很有必要。应考虑早期进行免疫调节治疗,尤其是对于 NMDAR 抗体滴度高的患者。